BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 21220330)

  • 1. CUB-domain-containing protein 1 (CDCP1) activates Src to promote melanoma metastasis.
    Liu H; Ong SE; Badu-Nkansah K; Schindler J; White FM; Hynes RO
    Proc Natl Acad Sci U S A; 2011 Jan; 108(4):1379-84. PubMed ID: 21220330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The SRC-associated protein CUB Domain-Containing Protein-1 regulates adhesion and motility.
    Benes CH; Poulogiannis G; Cantley LC; Soltoff SP
    Oncogene; 2012 Feb; 31(5):653-63. PubMed ID: 21725358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of autophagy by CUB domain-containing protein 1 signaling is essential for anchorage-independent survival of lung cancer cells.
    Uekita T; Fujii S; Miyazawa Y; Hashiguchi A; Abe H; Sakamoto M; Sakai R
    Cancer Sci; 2013 Jul; 104(7):865-70. PubMed ID: 23510015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural requirements for cub domain containing protein 1 (CDCP1) and Src dependent cell transformation.
    Kollmorgen G; Bossenmaier B; Niederfellner G; Häring HU; Lammers R
    PLoS One; 2012; 7(12):e53050. PubMed ID: 23300860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CUB-domain-containing protein 1 overexpression in solid cancers promotes cancer cell growth by activating Src family kinases.
    Leroy C; Shen Q; Strande V; Meyer R; McLaughlin ME; Lezan E; Bentires-Alj M; Voshol H; Bonenfant D; Alex Gaither L
    Oncogene; 2015 Oct; 34(44):5593-8. PubMed ID: 25728678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CUB domain-containing protein 1 is a novel regulator of anoikis resistance in lung adenocarcinoma.
    Uekita T; Jia L; Narisawa-Saito M; Yokota J; Kiyono T; Sakai R
    Mol Cell Biol; 2007 Nov; 27(21):7649-60. PubMed ID: 17785447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncogenic Ras/ERK signaling activates CDCP1 to promote tumor invasion and metastasis.
    Uekita T; Fujii S; Miyazawa Y; Iwakawa R; Narisawa-Saito M; Nakashima K; Tsuta K; Tsuda H; Kiyono T; Yokota J; Sakai R
    Mol Cancer Res; 2014 Oct; 12(10):1449-59. PubMed ID: 24939643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global phosphotyrosine proteomics identifies PKCδ as a marker of responsiveness to Src inhibition in colorectal cancer.
    McKinley ET; Liu H; McDonald WH; Luo W; Zhao P; Coffey RJ; Hanks SK; Manning HC
    PLoS One; 2013; 8(11):e80207. PubMed ID: 24260357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CUB domain-containing protein 1, a prognostic factor for human pancreatic cancers, promotes cell migration and extracellular matrix degradation.
    Miyazawa Y; Uekita T; Hiraoka N; Fujii S; Kosuge T; Kanai Y; Nojima Y; Sakai R
    Cancer Res; 2010 Jun; 70(12):5136-46. PubMed ID: 20501830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FBXL14 abolishes breast cancer progression by targeting CDCP1 for proteasomal degradation.
    Cui YH; Kim H; Lee M; Yi JM; Kim RK; Uddin N; Yoo KC; Kang JH; Choi MY; Cha HJ; Kwon OS; Bae IH; Kim MJ; Kaushik N; Lee SJ
    Oncogene; 2018 Oct; 37(43):5794-5809. PubMed ID: 29973690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of inside-out β1-integrin activation by CDCP1.
    Pollan SG; Huang F; Sperger JM; Lang JM; Morrissey C; Cress AE; Chu CY; Bhowmick NA; You S; Freeman MR; Spassov DS; Moasser MM; Carter WG; Satapathy SR; Shah K; Knudsen BS
    Oncogene; 2018 May; 37(21):2817-2836. PubMed ID: 29511352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of CDCP1 as a hypoxia-inducible factor 2α (HIF-2α) target gene that is associated with survival in clear cell renal cell carcinoma patients.
    Emerling BM; Benes CH; Poulogiannis G; Bell EL; Courtney K; Liu H; Choo-Wing R; Bellinger G; Tsukazawa KS; Brown V; Signoretti S; Soltoff SP; Cantley LC
    Proc Natl Acad Sci U S A; 2013 Feb; 110(9):3483-8. PubMed ID: 23378636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular settings mediating Src Substrate switching between focal adhesion kinase tyrosine 861 and CUB-domain-containing protein 1 (CDCP1) tyrosine 734.
    Wortmann A; He Y; Christensen ME; Linn M; Lumley JW; Pollock PM; Waterhouse NJ; Hooper JD
    J Biol Chem; 2011 Dec; 286(49):42303-42315. PubMed ID: 21994943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Src-family kinase inhibitors block early steps of caveolin-1-enhanced lung metastasis by melanoma cells.
    Ortiz R; Díaz J; Díaz-Valdivia N; Martínez S; Simón L; Contreras P; Lobos-González L; Guerrero S; Leyton L; Quest AFG
    Biochem Pharmacol; 2020 Jul; 177():113941. PubMed ID: 32240650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EGF inhibits constitutive internalization and palmitoylation-dependent degradation of membrane-spanning procancer CDCP1 promoting its availability on the cell surface.
    Adams MN; Harrington BS; He Y; Davies CM; Wallace SJ; Chetty NP; Crandon AJ; Oliveira NB; Shannon CM; Coward JI; Lumley JW; Perrin LC; Armes JE; Hooper JD
    Oncogene; 2015 Mar; 34(11):1375-83. PubMed ID: 24681947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell line and patient-derived xenograft models reveal elevated CDCP1 as a target in high-grade serous ovarian cancer.
    Harrington BS; He Y; Davies CM; Wallace SJ; Adams MN; Beaven EA; Roche DK; Kennedy C; Chetty NP; Crandon AJ; Flatley C; Oliveira NB; Shannon CM; deFazio A; Tinker AV; Gilks CB; Gabrielli B; Brennan DJ; Coward JI; Armes JE; Perrin LC; Hooper JD
    Br J Cancer; 2016 Feb; 114(4):417-26. PubMed ID: 26882065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KAI1 suppresses HIF-1α and VEGF expression by blocking CDCP1-enhanced Src activation in prostate cancer.
    Park JJ; Jin YB; Lee YJ; Lee JS; Lee YS; Ko YG; Lee M
    BMC Cancer; 2012 Mar; 12():81. PubMed ID: 22390300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CUB domain-containing protein 1 and the epidermal growth factor receptor cooperate to induce cell detachment.
    Law ME; Ferreira RB; Davis BJ; Higgins PJ; Kim JS; Castellano RK; Chen S; Luesch H; Law BK
    Breast Cancer Res; 2016 Aug; 18(1):80. PubMed ID: 27495374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CDCP1 drives triple-negative breast cancer metastasis through reduction of lipid-droplet abundance and stimulation of fatty acid oxidation.
    Wright HJ; Hou J; Xu B; Cortez M; Potma EO; Tromberg BJ; Razorenova OV
    Proc Natl Acad Sci U S A; 2017 Aug; 114(32):E6556-E6565. PubMed ID: 28739932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional role of cell surface CUB domain-containing protein 1 in tumor cell dissemination.
    Deryugina EI; Conn EM; Wortmann A; Partridge JJ; Kupriyanova TA; Ardi VC; Hooper JD; Quigley JP
    Mol Cancer Res; 2009 Aug; 7(8):1197-211. PubMed ID: 19671673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.